Simplify Logo

Internship

Finance Intern

Posted on 5/7/2024

Editas Medicine

Editas Medicine

201-500 employees

Develops CRISPR-based gene editing therapies

Hardware
Biotechnology
Healthcare

Cambridge, MA, USA

Category
Corporate Finance
Financial Planning and Analysis (FP&A)
Risk Management
Finance & Banking
Required Skills
Communications
Oracle
Requirements
  • Proficiency in Microsoft Office (particularly Excel)
  • Pursuing a bachelor's degree in Finance, Accounting, Business, or Economics
  • Excellent interpersonal, written communication, and organizational skills
  • Ability to work within and meet all deadlines while executing on multiple deliverables
  • Self-motivated and strong ability to solve problems effectively and efficiently
Responsibilities
  • Applying finance, accounting, and analytical principles to help with routine and ad hoc budgeting, forecasting, and business planning activities as needed
  • Facilitating month-end review through the preparation of financial reports to enable variance analysis, performance commentary, and presentation to management
  • Developing a strong understanding of our financial systems (Adaptive Planning and Oracle Fusion) to make meaningful contributions and enhancements to our tracking and reporting processes
  • Undertaking and participating in special projects designed to develop professional skills and expertise

Editas Medicine is a leader in the biotechnology industry, focused on developing cutting-edge CRISPR gene editing technologies to create transformative medicines for serious diseases. This focus places the company at the forefront of genetic research and therapy development, providing a dynamic and pioneering environment for its employees. As a workplace, it promises a culture of constant learning and innovation, ideal for those passionate about advancing healthcare and contributing to vital medical breakthroughs.

Company Stage

IPO

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

19%

1 year growth

24%

2 year growth

13%
INACTIVE